28 Oct Is It Mum Burnout or Perimenopause? The Signs Busy Mums Often Miss
Health Notice: Hormone replacement therapy, including bioidentical and pellet therapy, should only be prescribed and monitored by your healthcare provider. The Menopause Society and ACOG don’t recommend compounded pellets for routine use. The doses aren’t FDA-approved, can’t be adjusted or removed once placed, and can raise hormone levels too high. See a doctor promptly for very heavy or prolonged bleeding, bleeding between periods, or any bleeding after menopause as well as your regular checkups. If you are experiencing persistent low mood or thoughts of harming yourself, call or text 988 (Suicide & Crisis Lifeline) or text HOME to 741741 in the U.S.; in the UK, call Samaritans free on 116 123.
Editorial Notice: This article is for general information and is not specific medical advice. Clinics and providers named or linked in this article are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc.
It's 3 pm, and you've hit the wall. You've done the school run, answered a pile of work emails, tracked down a missing PE kit, and forgotten why you walked upstairs. By teatime, you're snapping at the kids over nothing, and at 3 a.m., you're wide awake with your mind racing. Most of us shrug and call it mum life. Yet hormone specialists, including the team at Bio Hormone Center, a physician-led hormone replacement clinic headed by board-certified gynecologist Dr. Michael Augustino, according to the clinic, list fatigue, brain fog, moodiness, and poor sleep among the most common signs of shifting hormones.
So if you're knackered in a way a lie-in never fixes, it's worth asking a different question. Is this burnout, or could it be perimenopause? The honest answer is that it can be both, and knowing the difference changes what actually helps.
Dr. Mikkola[/caption]
Tomi Mikkola MD
Associate Professor
Helsinki University Hospital
Department of Obstetrics and Gynecology
Helsinki, Finland
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: In Finland we have perhaps the most comprehensive and reliable medical registers in the world. Thus, with my research group I have conducted various large studies evaluating association of postmenopausal hormone therapy use and various major diseases (see e.g. the references in the B;MJ paper). There has been various smaller studies indicating that hormone therapy might be protective for all kinds of dementias, also Alzheimer’s disease.
However, we have quite recently shown that hormone therapy seems to lower the mortality risk of vascular dementia but not Alzheimer’s disease (Mikkola TS et al. J Clin Endocrinol Metab 2017;102:870-7). Now in this upcoming BMJ-paper we report in a very large case-control study (83 688 women with Alzheimer’s disease and same number of control women without the disease) that systemic hormone therapy was associated with a 9-17% increased risk of Alzheimer’s disease.
Furthermore, this risk increase is particularly in women using hormone therapy long, for more than 10 years. This was somewhat surprising finding, but it underlines the fact that mechanisms behind Alzheimer’s disease are likely quite different than in vascular dementia, where the risk factors are similar as in cardiovascular disease. We have also shown how hormone therapy protects against cardiovascular disease, particularly in women who initiate hormone therapy soon after menopause.




